[go: up one dir, main page]

PT999843E - Composicoes farmaceuticas contendo vitamina d e calcio, sua preparacao e uso terapeutico - Google Patents

Composicoes farmaceuticas contendo vitamina d e calcio, sua preparacao e uso terapeutico

Info

Publication number
PT999843E
PT999843E PT98941395T PT98941395T PT999843E PT 999843 E PT999843 E PT 999843E PT 98941395 T PT98941395 T PT 98941395T PT 98941395 T PT98941395 T PT 98941395T PT 999843 E PT999843 E PT 999843E
Authority
PT
Portugal
Prior art keywords
calcium
preparation
containing vitamin
pharmaceutical compositions
compositions containing
Prior art date
Application number
PT98941395T
Other languages
English (en)
Inventor
Maurizio Valleri
Alessandro Tosetti
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Publication of PT999843E publication Critical patent/PT999843E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT98941395T 1997-07-30 1998-07-21 Composicoes farmaceuticas contendo vitamina d e calcio, sua preparacao e uso terapeutico PT999843E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97FI000184A ITFI970184A1 (it) 1997-07-30 1997-07-30 Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico

Publications (1)

Publication Number Publication Date
PT999843E true PT999843E (pt) 2004-11-30

Family

ID=11352223

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98941395T PT999843E (pt) 1997-07-30 1998-07-21 Composicoes farmaceuticas contendo vitamina d e calcio, sua preparacao e uso terapeutico

Country Status (29)

Country Link
US (1) US7067154B1 (pt)
EP (1) EP0999843B1 (pt)
JP (1) JP4497496B2 (pt)
KR (1) KR100573421B1 (pt)
AT (1) ATE271387T1 (pt)
AU (1) AU8978198A (pt)
BG (1) BG65044B1 (pt)
BR (1) BR9810832B1 (pt)
CA (1) CA2299420C (pt)
CZ (1) CZ297670B6 (pt)
DE (1) DE69825164D1 (pt)
EA (1) EA002492B1 (pt)
EE (1) EE04046B1 (pt)
ES (1) ES2223135T3 (pt)
HK (1) HK1027751A1 (pt)
HU (1) HU226112B1 (pt)
ID (1) ID23504A (pt)
IL (1) IL134268A0 (pt)
IS (1) IS5359A (pt)
IT (1) ITFI970184A1 (pt)
NO (1) NO20000310L (pt)
PL (1) PL189295B1 (pt)
PT (1) PT999843E (pt)
RS (1) RS49703B (pt)
SI (1) SI0999843T1 (pt)
SK (1) SK284873B6 (pt)
TR (1) TR200000261T2 (pt)
UA (1) UA61968C2 (pt)
WO (1) WO1999006051A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040071789A1 (en) * 2002-02-14 2004-04-15 Baron John A Calcium supplementation to reduce prostate cancer risk
ES2192136B1 (es) * 2002-01-04 2005-03-16 Italfarmaco, S.A. Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.
ITFI20030194A1 (it) * 2003-07-17 2005-01-18 Menarini Int Operations Lu Sa Composizione farmaceutiche effervescenti contenenti
BRPI0511520B8 (pt) 2004-05-24 2021-05-25 Nycomed Pharma As material particulado, forma de dosagem sólida, e, processos para a preparação de um material particulado, e para preparar um comprimido
JP4996458B2 (ja) 2004-06-01 2012-08-08 ニコメド ファーマ エイエス 活性物質としてカルシウム含有化合物を含み、咀嚼し、舐め、飲み込むことのできる錠剤
WO2006082501A2 (en) 2005-02-03 2006-08-10 Nycomed Pharma As Fast wet-massing method for the preparation of calcium-containing compositions
EA010751B1 (ru) 2005-02-03 2008-10-30 Никомед Фарма Ас Гранулирование из расплава композиции, содержащей кальцийсодержащее соединение
US20070122477A1 (en) * 2005-10-12 2007-05-31 Cytochroma, Inc. Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency
UA95093C2 (uk) * 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
UA92052C2 (ru) * 2005-12-07 2010-09-27 Нікомед Фарма Ас Предварительно уплотненные кальциесодержащие композиции
MXPA05014091A (es) * 2005-12-20 2007-06-20 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden derivados de esteroides sinteticos, minerales y el metabolito activo de la vitamina d, 1,25(oh)2d3 (calcitriol) para la prevencion y tratamiento de la osteoporosis y el control de los sintomas de la menopaus
CA2835910C (en) * 2007-04-25 2016-06-28 Warner Chilcott Company, Llc Improved vitamin d content uniformity in pharmaceutical dosage forms
KR101807318B1 (ko) 2008-11-17 2018-01-10 다케다 에이에스 개량된 용출 안정성을 지닌 탄산칼슘 정제
TR200900878A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
TR200900880A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik bileşimler.
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
US20120015913A1 (en) * 2010-07-15 2012-01-19 Delansorne Remi Formulations of 14-EPI-Analogues of Vitamin D
WO2015020191A1 (ja) * 2013-08-09 2015-02-12 日東薬品工業株式会社 カルシウム剤
CN105166935B (zh) * 2015-09-01 2018-08-31 张伟 一种含有维生素d3的液体制剂及其制备方法
KR20210005224A (ko) 2018-05-02 2021-01-13 훼링 비.브이. 개선된 약학적 제형
KR102211287B1 (ko) * 2018-12-21 2021-02-03 (주)휴온스 비타민 d 또는 이의 유도체를 포함하는 안정성이 개선된 액상 제제
CA3211610A1 (en) * 2021-03-12 2022-09-15 Michael S. Daniel Oral products with self-emulsifying system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073271A1 (en) * 1969-12-11 1971-10-01 Boivin Jean Calcium salt - vitamin d2 compn - for treatment of decalcification of
ZA813205B (en) * 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
DK8603837A (pt) * 1985-08-13 1987-02-14
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
DE69124223T2 (de) * 1990-02-05 1997-04-30 Lifescience Corp Vitamine und mineralien enthaltende nahrungszusätze
CA2080818A1 (en) * 1990-05-16 1991-11-17 Zbigniew Walaszek Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyerproliferative disorders
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
IL103224A (en) * 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
FR2724844B1 (fr) 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
FR2760639B1 (fr) * 1997-03-14 2000-09-22 Innothera Lab Sa Association therapeutique mineralo-vitaminique sous forme de preparation unitaire liquide buvable

Also Published As

Publication number Publication date
JP4497496B2 (ja) 2010-07-07
ATE271387T1 (de) 2004-08-15
EA200000181A1 (ru) 2000-10-30
KR100573421B1 (ko) 2006-04-26
IS5359A (is) 2000-01-24
ITFI970184A1 (it) 1999-01-30
BG104057A (en) 2000-07-31
BR9810832A (pt) 2000-07-25
EP0999843B1 (en) 2004-07-21
BG65044B1 (bg) 2007-01-31
PL338237A1 (en) 2000-10-09
DE69825164D1 (de) 2004-08-26
US7067154B1 (en) 2006-06-27
HK1027751A1 (en) 2001-01-23
CA2299420C (en) 2009-04-21
JP2001511453A (ja) 2001-08-14
ES2223135T3 (es) 2005-02-16
RS49703B (sr) 2007-12-31
AU8978198A (en) 1999-02-22
SI0999843T1 (en) 2005-02-28
PL189295B1 (pl) 2005-07-29
NO20000310D0 (no) 2000-01-21
HUP0100539A2 (hu) 2001-08-28
EE200000054A (et) 2000-10-16
KR20010022319A (ko) 2001-03-15
NO20000310L (no) 2000-01-21
TR200000261T2 (tr) 2000-09-21
UA61968C2 (en) 2003-12-15
YU3700A (sh) 2002-11-15
WO1999006051A1 (en) 1999-02-11
ID23504A (id) 2000-04-27
SK802000A3 (en) 2000-07-11
EP0999843A1 (en) 2000-05-17
CZ2000199A3 (cs) 2000-05-17
IL134268A0 (en) 2001-04-30
EA002492B1 (ru) 2002-06-27
HU226112B1 (en) 2008-04-28
EE04046B1 (et) 2003-06-16
CZ297670B6 (cs) 2007-02-28
BR9810832B1 (pt) 2010-11-16
CA2299420A1 (en) 1999-02-11
SK284873B6 (sk) 2006-01-05

Similar Documents

Publication Publication Date Title
PT999843E (pt) Composicoes farmaceuticas contendo vitamina d e calcio, sua preparacao e uso terapeutico
HUP9802448A2 (hu) Vérlemezke-aggregáció inhibitorvegyületei, ezek előállítása és alkalmazása és gyógyászati készítmények
HU9600162D0 (en) Use of an antagonist of cgrp in cosmetic, pharmaceutical or dermatological composition and the cosmetic compositions
GR3031526T3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
HUP9904046A3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing the same
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
EP0824915A3 (de) Herstellung von Glycoglycerolipiden, deren Verwendung als Tenside sowie kosmetische oder dermatologische Zubereitungen, solche Glycoglycerolipide enthaltend
HUP9801880A3 (en) Novel cryptophycins, their use and pharmaceutical compositions containing them
BR0115518A (pt) Kit de repinotan
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
GR3033591T3 (en) Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
SE9802937D0 (sv) Novel compounds
GR3036410T3 (en) Taxoids, their preparation and pharmaceutical compositions containing them
GR3034203T3 (en) Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
BG101849A (en) Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions
ZA9711734B (en) Novel farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments.
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
GR3036411T3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
FR2684299B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride.
FR2772764B1 (fr) Nouveaux inhibiteurs de farnesyle transferase, leur preparation, les compositions pharmaceutiques qui les contiennent et leur utilisation pour la preparation de medicaments
IT1231439B (it) Composizione dietetica e/o farmaceutica per uso orale, contenente un principio attivo scelto tra integratori dietetici e farmaci in veicolo oleoso
SI0821680T1 (en) Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
SI0817780T1 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same